EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product

Samantha C Redden, David J Sun, Yao-Wei W Wang, Elizabeth Hartwell iD, Jessica C Cardenas, Scott D Olson, Bryan A Cotton iD

Transfusion · 2026

DOI: 10.1111/trf.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Samantha C Redden und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Translational Injury Research, University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Plasma, Hemostasis, Blood Donors. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Trauma Research and Combat Casualty Care Collaborative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent studies have linked trauma patient outcomes to the plasma donor's sex, with premenopausal females associated with improved survival and lower organ failure. Currently, green‐colored plasma (due to oral contraceptive use) is removed from the donor pool. We set out to evaluate the hemostatic potential of green plasma. Study Design & Methods We obtained 90 units of plasma from our regional blood center: 30 units of visible green plasma and 60 units of standard‐color plasma divided between male and female donors. We collected clinical data such as age, sex, ethnicity, and number of pregnancies. We then assessed the hemostatic potential through thrombelastography ( TEG ), calibrated automated thrombography ( CAT ), and clotting factor levels.

Results

Green plasma unit donors were younger than standard‐color female and male donor units (median age 27 vs. 58 vs. 54) and had fewer pregnancies than their non‐green female counterparts (median 0 vs. 2); (both p < 0.001). All TEG values, as well as CAT lag time, thrombin potential, and peak thrombin were more hypercoagulable in the green plasma group compared to standard‐color female and male donor units; all p < 0.05. In addition, the majority of factor levels (including II, VII, IX, X, and fibrinogen) were higher in green donor plasma; all p < 0.05.

Discussion

Based on our data, green plasma has superior hemostatic potential without any other aberrant characteristics, possibly justifying the use of green plasma in transfusion medicine. Reintroducing this product will help to expand on the plasma donor pool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmaHemostasisBlood DonorsHumansFemaleMaleAdultMiddle AgedThrombelastographyBlood Coagulation FactorsBlood DonationColor

Substanzen

Blood Coagulation Factors

Autor:innen und Institutionen

  • The Center for Translational Injury Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • The Department of Surgery, McGovern Medical School, Houston, Texas, USA.
  • Gulf Coast Regional Blood Center, Houston, Texas, USA.
  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Elizabeth Hartwell, Bryan A Cotton

Förderung

  • Trauma Research and Combat Casualty Care Collaborative

Zitieren

APA

Redden, S. C., Sun, D. J., Wang, Y. W., Hartwell, E., Cardenas, J. C., Olson, S. D., & Cotton, B. A. (2026). An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product. Transfusion. https://doi.org/10.1111/trf.70115

Vancouver

Redden SC, Sun DJ, Wang YW, Hartwell E, Cardenas JC, Olson SD, et al. An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product. Transfusion. 2026. doi:10.1111/trf.70115

BibTeX
@article{Redden2026,
  author = {Redden, Samantha C and Sun, David J and Wang, Yao-Wei W and Hartwell, Elizabeth and Cardenas, Jessica C and Olson, Scott D and Cotton, Bryan A},
  title = {An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70115}
}
Kostenlos starten →